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The influence of the mammalian retinal circadian clock on retinal physiology and function is widely recognized, yet the
cellular elements and neural regulation of retinal circadian pacemaking remain unclear due to the challenge of long-
term culture of adult mammalian retina and the lack of an ideal experimental measure of the retinal circadian clock. In
the current study, we developed a protocol for long-term culture of intact mouse retinas, which allows retinal circadian
rhythms to be monitored in real time as luminescence rhythms from a PERIOD2::LUCIFERASE (PER2::LUC) clock gene
reporter. With this in vitro assay, we studied the characteristics and location within the retina of circadian PER2::LUC
rhythms, the influence of major retinal neurotransmitters, and the resetting of the retinal circadian clock by light.
Retinal PER2::LUC rhythms were routinely measured from whole-mount retinal explants for 10 d and for up to 30 d.
Imaging of vertical retinal slices demonstrated that the rhythmic luminescence signals were concentrated in the inner
nuclear layer. Interruption of cell communication via the major neurotransmitter systems of photoreceptors and
ganglion cells (melatonin and glutamate) and the inner nuclear layer (dopamine, acetylcholine, GABA, glycine, and
glutamate) did not disrupt generation of retinal circadian PER2::LUC rhythms, nor did interruption of intercellular
communication through sodium-dependent action potentials or connexin 36 (cx36)-containing gap junctions,
indicating that PER2::LUC rhythms generation in the inner nuclear layer is likely cell autonomous. However,
dopamine, acting through D1 receptors, and GABA, acting through membrane hyperpolarization and casein kinase, set
the phase and amplitude of retinal PER2::LUC rhythms, respectively. Light pulses reset the phase of the in vitro retinal
oscillator and dopamine D1 receptor antagonists attenuated these phase shifts. Thus, dopamine and GABA act at the
molecular level of PER proteins to play key roles in the organization of the retinal circadian clock.
Citation: Ruan G-X, Allen GC, Yamazaki S, McMahon DG (2008) An autonomous circadian clock in the inner mouse retina regulated by dopamine and GABA. PLoS Biol 6(10):
e249. doi:10.1371/journal.pbio.0060249
Introduction
The vertebrate retina is both a sensory organ and an
endogenous circadian clock. As the locus of visual photo-
transduction, the retina initiates many organismal responses
to light, and as a circadian clock, the retina expresses many
physiological or functional circadian rhythms, including
photoreceptor disc shedding [1–4], visual sensitivity [5–8],
rod–cone balance[9,10], electroretinogram (ERG) b-wave
amplitude [11–13], extracellular pH [14], melatonin release
[15–18], dopamine synthesis [19,20], gamma-aminobutyric
acid (GABA) turnover rate and release [21], PKC level [22],
intraocular pressure [23,24], and gene expression [13]. In
mammals, the retina is the sole site for circadian photo-
transduction, and its output modiﬁes the rhythmicity, period,
and developmental organization of the central biological
clock, the suprachiasmatic nucleus (SCN) of the hypothal-
amus [25–27]. In addition, the mammalian retinal clock and
its outputs inﬂuence trophic processes in the eye, including
the susceptibility of photoreceptors to degeneration from
light damage [28], photoreceptor survival in animal models of
retinal degeneration [29], and the degree of refractive errors
in primate models of myopia [30]. Despite the widespread
inﬂuence of the mammalian retinal circadian clock on
retinal, visual, and circadian function, the cellular elements
and mechanisms comprising the retinal pacemaker remain to
be elucidated.
The mammalian retina contains all the major neuro-
transmitter systems, and to a large extent, retinal function
is mediated by neurotransmission. Glutamate is the prom-
inent excitatory neurotransmitter of the neuron types of
vertical pathways through the retina, including photorecep-
tors, bipolar, and ganglion cells [31,32]. The other major
excitatory neurotransmitter, acetylcholine (ACh), is produced
by a mirror-symmetric pair of amacrine cells [33]. The
inhibitory neurotransmitter GABA occurs in many different
subtypes of amacrine cells and in one or more subtypes of
horizontal cells [34]. The inhibitory neurotransmitter glycine
is present in most of the small-ﬁeld types of amacrine cells
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PLoS BIOLOGY[35]. Besides these four fast neurotransmitters, there are two
globally modulatory neurotransmitters, melatonin and dop-
amine, which are mutually inhibitory neurochemical outputs
of the retinal clock and are rhythmically released by photo-
receptors and dopaminergic amacrine cells, respectively
[19,36,37]. Melatonin and dopamine rhythms have served as
the principal experimental measures of the retinal circadian
clock, and previous models of retinal circadian organization
have postulated that communication through these two
transmitters is critical for overall retinal rhythmicity
[15,19,20,38,39]. However, these neurochemical assays of
clock output have left open questions of whether dopamine
or melatonin modulates the retinal molecular clock mecha-
nism itself and what roles they may play in the organization of
retinal clockworks.
Circadian clocks in mammalian tissues generate molecular
circadian rhythms through coupled transcription/translation
feedback loops in which the positive gene elements Clock and
Bmal1 interact with the negative gene elements Period (Per) 1
and 2, and Cryptochrome (Cry) 1 and 2, and in which casein
kinases, CKIe and CKId, set circadian period by phosphor-
ylating PER proteins to regulate their degradation and
nuclear localization [38,40]. Circadian rhythms of Per1
expression have been reported in the rat and mouse retina
[41,42]. We have previously shown that in photoreceptor-
degenerate mouse retinas, Per1, Per2, Cry1, Cry2, and Bmal1
mRNA levels exhibit statistically signiﬁcant variations over a
24-h sampling period under constant darkness conditions
[43]. Moreover, in a recent microarray study, 277 genes
representing a wide range of functions were found to show a
circadian rhythm of expression in the mouse retina in
constant darkness [13]. However, it is unclear from these in
vivo studies whether circadian rhythms of retinal gene
expression are self-sustained or driven by the master SCN
clock.
In the current study, we developed an in vitro retinal
explant culture protocol to monitor circadian rhythms in
clock gene expression in intact retinas of adult mice, which
harbor a knockin PERIOD2::LUCIFERASE (PER2::LUC) fu-
sion protein as a real-time reporter of circadian gene
dynamics [44]. Using this protocol, we studied the properties
and location of retinal PER2::LUC rhythms in vitro, the
inﬂuence of major retinal neurotransmitters, the roles of
sodium-dependent action potentials and connexin 36 (cx36)-
containing gap junctions in retinal PER2::LUC rhythms, and
light-induced phase resetting of retinal PER2::LUC rhythms.
Our ﬁndings support a model of retinal circadian organ-
ization in which rhythm generation occurs in the inner
nuclear layer independently of major forms of neural
communication, but in which dopamine and GABA play
critical roles in setting the phase and amplitude of the retinal
circadian clock.
Results
PER2::LUC Rhythms from Intact Mouse Retinas
To study the retinal circadian clock in the intact retina,
mPer2
Luc mice congenic on the C57BL/6J background, in
which melatonin levels are greatly reduced due to point
mutations in synthetic enzymes for melatonin [19,45], were
crossed to C3H rd1/rd1 mice to obtain F1 hybrid B6C3 mice.
These mice have one wild-type allele at the melatonin and rd1
loci, synthesize and secrete normal levels of melatonin [46],
and do not undergo photoreceptor degeneration. When
retinal explants from B6C3 F1 mice were cultured under
standard conditions (medium 199 or DMEM, air, 37 8C), they
exhibited only low-amplitude PER2::LUC oscillations (Figure
S1). However, when retinal explants were ﬁrst cultured in
neurobasal medium in 5% CO2 at 37 8C for 24 h in vitro and
subsequently transferred to medium 199 as before, PER2::-
LUC expression was robustly rhythmic for numerous circa-
dian cycles (Figure 1A). Peak-to-trough amplitude typically
increased on the second cycle in medium 199, after which the
amplitude gradually decreased over 9–10 d (Figure 1A). The
ﬁrst peak of PER2::LUC expression occurred at hour 14.81 6
0.29 of projected Zeitgeber time (ZT; i.e., 2.81 h after the time
of lights off in the mouse colony; mean 6 standard error of
the mean [SEM]; n ¼ 11). This was essentially identical to the
phase of PER2::LUC rhythms in photoreceptor-degenerate
retinas [43], and phase delayed by 2 h relative to the peak
times of SCN PER2::LUC rhythms [44]. Retinal Per2 mRNA
abundance is rhythmic in vivo, as sampled at 4-h intervals by
quantitative reverse transcriptase (RT)-PCR (Figure S2),
indicating that the luminescence signals recorded in vitro
faithfully reﬂect in vivo rhythmic processes. The phase of the
in vivo Per2 and of the in vitro PER2::LUC rhythms were
similar, suggesting that the culture procedure itself does not
greatly affect the phase of retinal molecular oscillations.
However, the limited resolution of the in vivo data (4-h
intervals) prevented a more precise deﬁnition of the expected
delay between Per2 transcription and PER2::LUC lumines-
cence. As with the cultured SCN [47], a media change partially
restored the amplitude of luminescence rhythms (Figure 1C).
With media changes every 10 d, retinal rhythms could be
readily sustained for a month or more.
To control for whether bioluminescence light emission
produced by the PER2::LUC fusion protein inﬂuenced retinal
rhythms, we performed assays in which luciferin substrate was
absent from the medium, and thus, there was no retinal light
emission for the ﬁrst two circadian cycles in vitro. Luciferin
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Author Summary
The circadian clock in the mammalian retina regulates many retinal
functions, and its output modulates the central circadian clock in the
brain. Details about the cellular location and neural regulation of the
mammalian retinal circadian clock remain unclear, however, largely
due to the difficulty of maintaining long-term culture of adult
mammalian retina and the lack of an ideal experimental measure of
the retinal clock. We have circumvented these limitations by
developing a protocol for long-term culture of intact mouse retinas
to monitor circadian rhythms of clock gene expression in real time.
Using this protocol, we have localized expression of molecular
retinal circadian rhythms to the inner nuclear layer. We find
molecular retinal rhythms generation is independent of many forms
of signaling from photoreceptors and ganglion cells, or major forms
of neural communication within the inner nuclear layer, and have
characterized light-induced resetting of the retinal clock. Retinal
dopamine and GABA, although not necessary for the generation of
molecular retinal rhythms, were revealed to regulate the phase and
amplitude of retinal molecular rhythms, respectively, with dopamine
participating in light-induced resetting. Our data indicate that
dopamine and GABA play prominent roles in the organization of the
retinal circadian clock.(0.1 mM) was then added to the medium of experimental
explants, and an equal volume of vehicle was added to the
medium of control explants at the beginning of the rising
phase of the third cycle recorded in the LumiCycle. The
delayed addition of luciferin revealed rhythms of PER2::LUC
luminescence in the experimental explants that were similar
in amplitude and peak time to the ongoing rhythms of
control explants (n ¼ 4; Figure 1B), indicating that bio-
luminescence light emitted by the PER2::LUC reporter in
these retinas did not inﬂuence retinal PER2::LUC rhythms in
our in vitro assay.
Histological examination of vertical slices from cultured
retinas conﬁrmed that all retinal layers were intact in these
preparations, including photoreceptor cell bodies and outer
segments (Figure 1D). In addition, immunocytochemistry
with an antibody to tyrosine hydroxylase (TH), the rate-
limiting enzyme of dopamine synthesis, conﬁrmed that
cultured retinal explants retained a normal complement of
dopamine neurons (Figure 1E). Further immunocytochemical
analysis revealed that all the major retinal cell types,
including cone photoreceptors and horizontal, bipolar,
amacrine, and ganglion cells, were present and morpholog-
ically intact in cultured retinal explants (Figure S3).
Circadian Oscillation of PER2::LUC Bioluminescence in the
Inner Nuclear Layer
Multiple approaches, including in situ hybridization,
immunocytochemistry, and single-cell reverse-transcriptase
PCR (RT-PCR), have established that the Per2 clock gene is
expressed, with varying levels and frequencies, in all the
major subtypes of retinal neurons [13,43,48]. Thus, all retinal
cell subtypes could potentially contribute to the tissue-level
PER2::LUC luminescence rhythms recorded in our assays. To
localize the PER2::LUC signal within the retina, we imaged
vertical retinal slices for both bright-ﬁeld and luminescence
with a cooled charge-coupled device (CCD) camera. The
bioluminescence signal was concentrated in the mid-retina,
in the inner nuclear layer that contains the nuclei of the
horizontal, bipolar, and amacrine cells, with low levels of
luminescence detected in the photoreceptor and the ganglion
cell layers (Figure 2A). To conﬁrm that inner retinal
PER2::LUC is rhythmic, populations of retinal slices main-
tained in constant culture conditions were imaged at 6-h
intervals (n ¼ 2 independent runs; Figure 2B). PER2::LUC
bioluminescence in the inner nuclear layer exhibited a
circadian variation with a peak at projected ZT 8–14, close
to the peak time observed in whole retinal explant
preparations. In addition, individual retinal slices subject to
time-lapse imaging for 48 h showed similar circadian rhythms
in PER2::LUC bioluminescence emanating from the inner
nuclear layer (n ¼ 3 independent runs; Figure 2C). Similar
inner nuclear layer localization of PER2::LUC expression was
observed in retinas from C57BL/6J mice as well (unpublished
data). This indicates that the primary source of rhythmic
PER2::LUC luminescence signals in our retinal rhythms assay
is the inner nuclear layer, with minor contributions from the
other retinal layers.
PER2::LUC Rhythms in the Inner Nuclear Layer Are Not
Dependent upon Communication from Photoreceptors or
Ganglion Cells
Although the inner nuclear layer was the primary source of
rhythmic PER2::LUC signals in our vertical retinal slice
imaging, signaling from photoreceptors or ganglion cells
might play an important role in generating or sustaining
these rhythms. To test this possibility, we examined the
inﬂuence of the main forms of cell communication from
photoreceptors (melatonin and glutamate) and ganglion cells
(glutamate, sodium-dependent action potentials, and cx36-
containing gap junctions) on retinal PER2::LUC rhythms.
To determine whether melatonin signaling is required to
maintain retinal rhythmicity in clock gene expression, we
assayed luminescence rhythms from retinal explants derived
Figure 1. Bioluminescence Rhythms from mPer2
Luc Mouse Retinal
Explants
(A) A representative PER2::LUC bioluminescence trace recorded from a
B6C3 mPer2
Luc mouse retinal explant.
(B) A representative PER2::LUC bioluminescence trace recorded from a
mouse retinal explant in which luciferin substrate was absent from the
medium in the first two cycles. Arrow indicates addition of luciferin.
(C) Long-term culture of an intact mouse retinal explant showing
persistent circadian rhythms in PER2::LUC expression. Arrows indicate
times of media changes.
(D) Representative DIC image of vertical retinal sections. Retinal explants
were cultured for 9 d in vitro (DIV), and vertical retinal slices were cut
with a tissue slicer at 150 lm. GCL, ganglion cell layer; INL, inner nuclear
layer; IPL, inner plexiform layer; ONL, outer nuclear layer; OPL, outer
plexiform layer; OS, photoreceptor outer segments. Scale bar represents
20 lm.
(E) Flat-mount view showing tyrosine hydroxylase immunoreactivity in
retinal explants that were cultured for 9 DIV. The immunoreactive cells
with relatively large somata and two to three thick primary processes
that arise from the cell body are dopaminergic amacrine cells, whereas
the immunoreactive cells with relatively small cell body and very few
processes are type 2 catecholamine amacrine cells. Scale bar represents
20 lm.
doi:10.1371/journal.pbio.0060249.g001
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Luc C57BL/6J mice, in which melatonin synthesis is
genetically blunted [19,45]. Circadian rhythms of PER2::LUC
expression in C57BL/6J retinas were similar in their sustained
nature to those of B6C3 F1 retinas (n¼6 each; Figure 3A and
3B), which synthesize and secrete normal levels of melatonin
[46]. Similarly, B6C3 retinas, treated with continuous appli-
cation of 10 nM melatonin or continuous blockade of
melatonin MT1 receptors with 5 lM luzindole, also exhibited
robust circadian gene expression rhythms (n ¼6 each; Figure
3C and 3D). Taken together, these results indicate that the
mouse retina requires neither normal levels of melatonin nor
melatonin rhythmicity to maintain PER2::LUC rhythms.
Glutamate is an excitatory neurotransmitter used by
photoreceptors, ganglion, bipolar, and amacrine cells. To
examine the inﬂuence of glutamate on retinal PER2::LUC
rhythms, we either activated its receptors with L-glutamate (1
mM; n¼4; Figure 3E), or blocked its receptors with kynurenic
acid (0.5 mM; n ¼ 4; Figure 3F), a broad-spectrum glutamate
receptor antagonist. Neither of these treatments exhibited
marked effects on the amplitude or period of retinal
PER2::LUC rhythms (n ¼ 3 each), indicating that glutamater-
gic neurotransmission is not required for maintenance of
retinal PER2::LUC rhythms.
In the mammalian retina, ganglion cells and dopaminergic
amacrine cells require sodium-dependent action potentials
for evoked neurotransmitter release and subsequent chemical
communication [49]. In addition, in the SCN pacemaker,
sodium-dependent action potentials are critical for molec-
ular rhythms generation in individual neurons and for
cellular synchronization [50]. Thus, we tested the role of
sodium-dependent action potentials in the retinal circadian
Figure 2. Circadian Oscillation of PER2::LUC Bioluminescence in the Inner
Nuclear Layer
(A) DIC image (left panel) and luminescence image (right panel) of a
vertical retinal slice. Retinal slices were prepared around ZT 4, incubated
in CO2 incubator for 1 d, and then imaged. Note that bioluminescence
signals were primarily located in the inner nuclear layer. GCL, ganglion
cell layer; INL, inner nuclear layer; IPL, inner plexiform layer; ONL, outer
nuclear layer; OPL, outer plexiform layer; OS, photoreceptor outer
segments. Scale bar represents 50 lm.
(B) PER2::LUC bioluminescence in the inner nuclear layer of cultured
vertical retinal slices showed a circadian variation with a peak at
projected ZT 8–14. Shown are representative images acquired by 30-min
exposures at 6-h intervals. Arrows point to membrane filters that became
visible when signals in the inner nuclear layer were high. Scale bar
represents 100 lm.
(C) Continuous recording of PER2::LUC bioluminescence in a representa-
tive cultured vertical retinal slice. In this experiment, retinal slices were
prepared around ZT 4, incubated in CO2 incubator for 2 d, and then
images (30-min exposure) were continuously collected for 47 h, starting
at projected ZT 9.
doi:10.1371/journal.pbio.0060249.g002
Figure 3. Retinal PER2::LUC Rhythms Do Not Require Communication via
Melatonin, Glutamate, Sodium-Dependent Action Potentials or cx36-
Containing Gap Junctions
(A) mPer2
Luc retinal explants cultured from B6C3 mice exhibited
sustained circadian rhythms in PER2::LUC expression.
(B) mPer2
Luc retinal explants cultured from C57BL/6J mice also showed
robust circadian oscillation of PER2::LUC expression.
(C–H) Circadian PER2::LUC expression rhythms persisted upon continu-
ous application of: (C) melatonin (10 nM); (D) the melatonin MT1
receptor antagonist luzindole (5 lM); (E) L-glutamate (1 mM); (F) the
broad-spectrum glutamate receptor antagonist kynurenic acid (0.5 mM);
(G) the voltage-gated sodium channel blocker TTX (1 lM); and (H) the
gap junction block carbenoxolone (100 lM).
(I and J) Retinal explants cultured from cx36
 /  mice (I) and cx36
þ/  mice
(J) did not show differences in the damping rate of PER2::LUC rhythms.
Bars indicate the duration of treatment.
doi:10.1371/journal.pbio.0060249.g003
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Inner Retinal Clockpacemaker with the sodium channel blocker tetrodotoxin
(TTX), previously shown to damp tissue and cellular gene
expression rhythms in in vitro SCN cultures [50,51]. Retinal
PER2::LUC rhythms persisted undiminished upon continuous
application of 1 lM TTX, and there was no signiﬁcant
difference in e-fold damping rate between TTX treatment
and vehicle (3.92 6 0.22 d vs. 3.82 6 0.34 d; p . 0.05; n ¼ 5
each; Student’s t-test; Figure 3G). This concentration of TTX
was conﬁrmed to block spontaneous action potentials in
ganglion cells and in dopaminergic neurons (unpublished
data). Therefore, sodium-dependent action potentials are not
required for retinal PER2::LUC rhythms generation.
Ganglion cells form extensive electrically coupled networks
via gap junctions. To test for the role of gap junctions, we
applied 100 lM carbenoxolone, a general gap junction
blocker, to mPer2
Luc retinal explants. Carbenoxolone did not
inﬂuence the amplitude or damping rate of retinal PER2::-
LUC rhythms (damping rate ¼ 3.54 6 0.18 days; n ¼ 5; Figure
3H). In addition, we examined the role of the gap junction
channel protein, cx36 in retinal PER2::LUC rhythms. Cx36 is
widely distributed in retinal gap junctions, is essential for
transmission of rod-mediated visual signals in the mammalian
retina [52], and comprises most of the junctions between
alpha ganglion and amacrine cells [53]. Interneuronal
communication via cx36 gap junctions also promotes
synchronous electrical activity in SCN neurons and coherent
circadian behavioral rhythms [54]. To test whether cx36-
mediated electrical coupling plays a role in the retinal
biological clock, we crossed mPer2
Luc mice with cx36
 /  mice
[55] to produce cx36 knockout mPer2
Luc mice. PER2::LUC
rhythms in retinas from both cx36
 /  and cx36
þ/  mice were
similar to mice wild type at the cx36 locus, and there was no
signiﬁcant difference in the damping rate between cx36
 / 
mice and cx36
þ/  mice (2.62 6 0.12 d vs. 2.74 6 0.33 d; p .
0.05; n ¼ 8 each; Figure 3I and 3J), suggesting that neuronal
synchrony was not degraded by cx36 knockout. Taken
together, these results suggest that communication through
gap junctions is also not required for retinal PER2::LUC
rhythms generation or for circadian neural synchrony in the
mouse retina.
Retinal PER2::LUC Rhythms Are Not Dependent upon
Communication within the Inner Nuclear Layer
The wide distribution of PER2::LUC expression across the
inner nuclear layer suggests the possibility that multiple inner
nuclear layer neuron types, including horizontal, bipolar, and
amacrine cells, could be sources for the rhythmic PER2::LUC
signals. Rhythms generation could be a network property
driven by a speciﬁc population of pacemaker neurons located
in the inner nuclear layer, which establish PER2::LUC
rhythmicity by neurotransmission. To test this possibility,
we examined the role of the principal neurotransmitters of
the inner nuclear layer: dopamine, acetylcholine, GABA, and
glycine.
We ﬁrst examined whether dopamine is required for
retinal PER2::LUC rhythms generation. PER2::LUC rhythms
persisted during depletion of retinal dopamine by 100 lM a-
methyl-L-tyrosine (L-AMPT) and 10 lM reserpine, an inhib-
itor of dopamine synthesis and of vesicular dopamine uptake,
respectively (n ¼ 4; Figure 4A). Dopamine depletion at 48 h
posttreatment was conﬁrmed with high-performance liquid
chromatography (HPLC). Whereas control retinas contained
0.93 6 0.08 ng/mg protein dopamine, L-AMPT–treated
retinas contained 0.50 6 0.06 ng/mg protein, and L-AMPT–
and reserpine-treated retinas contained undetectable levels
of dopamine (n ¼ 4 each). In addition, circadian PER2::LUC
expression rhythms persisted during continuous application
of the long-lasting dopamine agonist (6)-2-amino-6,7-dihy-
droxy-1,2,3,4-tetrahydronaphthalene (ADTN; 100 lM; in
Figure 4. Retinal PER2::LUC Rhythms Are Not Dependent on Commu-
nication via Dopamine, Acetylcholine, GABA, or Glycine
(A–F) Retinal circadian PER2::LUC expression rhythms persisted upon
continuous application of: (A) the TH inhibitor L-AMPT (100 lM) along
with the vesicular dopamine uptake inhibitor reserpine (10 lM); (B) the
dopamine receptor agonist ADTN (100 lM), in the presence of L-AA (100
lM); (C) the dopamine D1 receptor agonist SKF-38393 (50 lM) along
with the D2/D4 receptor agonist quinpirole hydrochloride (50 lM); (D)
the dopamine D1 receptor antagonist SCH-23390 (50 lM) along with the
D2 receptor antagonist sulpiride (50 lM); (E) the nonselective cholinergic
agonist carbamoylcholine chloride (100 lM); and (F) the nicotinic
acetylcholine receptor antagonist (þ)-tubocurarine (100 lM) along with
the muscarinic acetylcholine receptor antagonist atropine (100 lM).
(G) GABA (1 mM) greatly suppressed the amplitude of retinal PER2::LUC
rhythms.
(H) Retinal PER2::LUC rhythms persisted during blockade of GABA
receptors with the GABAA receptor antagonist SR-95531 (40 lM) along
with the GABAB receptor antagonist CGP-35348 (100 lM) and the GABAC
receptor antagonist TPMPA (100 lM).
(I and J) Retinal PER2::LUC rhythms persisted upon continuous
application of: (I) glycine (3 mM); and (J) the glycine receptor antagonist
strychnine hydrochloride (50 lM).
Bars indicate the duration of treatment.
doi:10.1371/journal.pbio.0060249.g004
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antioxidant]; n ¼ 4; Figure 4B). However, ADTN produced
perturbations in the waveform during the ﬁrst few cycles of
treatment and indeed changed the phase of retinal PER2::-
LUC rhythms (further analyzed below). Retinal PER2::LUC
rhythms also persisted during continuous application of the
D1 receptor agonist SKF-38393 and the D2/D4 receptor
agonist quinpirole hydrochloride (50 lM each; n ¼ 4; Figure
4C); or continuous blockade of dopamine receptors with the
D1 receptor antagonist SCH-23390 and the D2/D4 receptor
antagonist sulpiride (50 lM each; n ¼ 4; Figure 4D). These
data, along with our above-mentioned results demonstrating
that retinal PER2::LUC rhythms persisted in the presence of
TTX, form convergent lines of evidence suggesting that
neither dopaminergic transmission nor its rhythmicity is
necessary for ongoing retinal PER2::LUC circadian rhythms
generation.
The excitatory neurotransmitter ACh is employed by
specialized circuits and produced by a mirror-symmetric
pair of amacrine cells. Neither activation of ACh receptors
with the nonselective cholinergic agonist carbamoylcholine
chloride (100 lM; n ¼ 4; Figure 4E), nor blockade of ACh
receptors with a variety of antagonists including the nicotinic
acetylcholine receptor antagonist (þ)-tubocurarine (100 lM)
alone (unpublished data; n¼4), the muscarinic ACh receptor
antagonist atropine (100 lM) alone (unpublished data; n¼4),
or (þ)-tubocurarine and atropine together (n ¼ 4; Figure 4F),
had a noticeable effect on the amplitude or period of retinal
PER2::LUC rhythms.
The inhibitory neurotransmitter GABA is synthesized and
released by horizontal cells and several subtypes of amacrine
cells including dopaminergic amacrine cells. Activation of
GABA receptors with 1 mM GABA substantially suppressed
the amplitude of retinal PER2::LUC rhythms (n ¼ 4; Figure
4G). However, retinal PER2::LUC rhythms persisted during
blockade of GABA receptors with the GABAA receptor
antagonist SR-95531 (40 lM) along with the GABAB receptor
antagonist CGP-35348 (100 lM) and the GABAC receptor
antagonist 1, 2, 5, 6-tetrahydropyridine-4-yl methyl phos-
phinic acid (TPMPA; 100 lM; n ¼ 4; Figure 4H), indicating
that GABAergic transmission is not required for retinal
PER2::LUC rhythms generation. Manipulation of another
inhibitory neurotransmitter glycine (3 mM; n ¼ 4; Figure 4I)
or the glycine receptor antagonist strychnine (50 lM; n ¼ 4;
Figure 4J) did not exhibit marked effects on the phase,
amplitude, or period of retinal PER2::LUC rhythms, although
the baseline of PER2::LUC rhythms was modestly reduced.
Dopamine Sets the Phase of Retinal PER2::LUC Rhythms
Manipulation of dopaminergic neurotransmission pro-
duced perturbations in the waveform of retinal PER2::LUC
rhythms at the onset of treatments with dopaminergic
agonists, but did not damp or disrupt rhythms generation
(Figure 4A–4D). To test the effects of dopamine on retinal
phase, we applied dopaminergic reagents in a step protocol
beginning at different circadian times during the second
cycle, using the peak time as a phase reference point of
approximately circadian time (CT) 15. We then compared the
transient change in period (phase shift) of PER2::LUC
rhythms in reagent-treated explants relative to those of
vehicle-treated explants on the cycle ensuing initiation of
treatment (see Figure 5C legend for detail). Application of the
nonselective dopamine receptor agonist ADTN (100 lM; in
vehicle containing 100 lM L-AA), or the D1 dopamine
agonist SKF 38393 (50 lM) beginning in the early retinal
subjective day (CT 3), phase-advanced retinal rhythms by
approximately 1.5 h (Figure 5A and 5C). In contrast,
application of the D2/D4 receptor agonist quinpirole (50
Figure 5. Dopamine Shifts the Phase of Retinal PER2::LUC Rhythms
(A) Application of ADTN (100 lM) along with L-AA (100 lM) beginning at
CT 3 advanced PER2::LUC rhythms compared to L-AA (100 lM)
application alone.
(B) Application of the D1 receptor agonist SKF 38393 (50 lM) beginning
at CT 18 delayed PER2::LUC rhythms compared to vehicle (H2O).
Data shown in (A) and (B) were baseline corrected by calculating a 24-h
moving average of the raw data, and then the deviation from the
moving average was plotted as a function of days in culture. Bars
indicate the duration of treatment.
(C) Phase change following application of dopamine agonists. Briefly, the
peak times (as determined by ClockLab software) on the third cycle (after
treatment) were subtracted from the peak times on the second cycle
(before treatment) for both drug and vehicle, and then used to calculate
the phase change of drug versus vehicle controls. Bars show drug phase
changes (means 6 SEM), error bars from x axis show 6SEM for vehicle
controls in each group. Drug concentrations were as follows: ADTN, 100
lM; the D1 agonist SKF 38393, 50 lM; and the D2 agonist quinpirole, 50
lM. Double asterisks (**) indicate p , 0.01, Student’s t-test; n¼at least 4
for each drug treatment and for vehicle controls.
(D) Lack of phase change following application of melatonin reagents.
Phase change was calculated as in (C). Drug concentrations are indicated
above columns. Vehicles used for 10 nM melatonin (mel), 10 lM
melatonin, and 5 lM luzindole (luz) were 1 ll of 0.01% ethanol, 1 llo f
10% ethanol, and 1 ll of DMSO, respectively; n¼at least 4 for each drug
treatment and for vehicle controls. No significant effects were observed
(p . 0.05 for all).
doi:10.1371/journal.pbio.0060249.g005
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Inner Retinal ClocklM) at CT 3, did not reset retinal phase (Figure 5C), whereas
coapplication of the two agonists together produced phase
advances similar in amplitude to D1 agonist alone (Figure
5C). Application of D1 agonist, beginning at CT 18, induced
phase delays of approximately 1 h (Figure 5B and 5C),
whereas application of the D2 agonist at that phase did not
affect retinal phase (Figure 5C). Phase advances and delays
induced by dopamine agonists were stable and persisted for
multiple cycles. Although dopaminergic agonists were ap-
plied as a bolus and thus were potentially active for multiple
circadian cycles, the periods of molecular rhythms of treated
explants were only altered relative to controls for two cycles
following administration of dopaminergic reagents and then
stabilized, indicating that these reagents likely have a limited
effective half-life of about 48 h in our culture system. Acute
pulse application experiments, performed in an attempt to
deﬁne more precisely the phase dependence of the resetting
action of dopamine, did not yield useful data due to
artifactual phase shifts induced by the repeated media
changes themselves.
Manipulation of melatonin transmission did not have any
noticeable effects on the waveform of retinal PER2::LUC
rhythms (Figure 3C and 3D) and did not signiﬁcantly affect
the phase of retinal molecular rhythms. Neither application
of melatonin (10 nM), nor the melatonin receptor antagonist
luzindole (5 lM) signiﬁcantly altered the phase of retinal
PER2::LUC rhythms (Figure 5D). Melatonin and luzindole
were each applied beginning at two different phases of the
retinal rhythm, at approximately CT 3 or CT 18, but none of
these treatments resulted in a statistically signiﬁcant change
in retinal phase (Figure 5D). In addition, application of a
higher dose of melatonin (10 lM) to B6C3 retinas, or
application of 10 nM melatonin to C57BL/6J retinas also
failed to alter retinal phase (Figure 5D).
Light Resetting of the Phase of Retinal PER2::LUC Rhythms
Is Mediated In Part Through Dopamine D1 Receptors
To test the effects of light pulses on the phase of retinal
PER2::LUC rhythms, we prepared retinal explant cultures
under infrared illumination to preserve photoreceptor
function and subjected them to 1-h pulses of white light
(500 lux) at different circadian times during the second cycle
in vitro. Light pulses beginning in the early retinal subjective
night (CT 13) phase delayed retinal PER2::LUC rhythms by
approximately 2.3 h, whereas light pulses beginning in the
late retinal subjective night (CT 19.5) induced phase advances
of approximately 1.5 h (Figure 6A–6C). To determine whether
dopamine acting through D1 receptors mediates light
resetting of retinal PER2::LUC rhythms, we applied the D1
receptor antagonist SCH-23390 (50 lM) beginning 15 min
before starting 1-h light pulses at CT 13. Light-induced phase
delays were signiﬁcantly attenuated in the presence of SCH-
23390 compared to light alone (1.2 h, p , 0.01, Figure 6D).
Pretreating retinal explants with the D1 antagonist SCH-
23390 and the D2 receptor antagonist sulpiride (50 lM)
together prior to light pulse resulted in phase delays similar
in amplitude to D1 antagonist pretreatment alone (Figure
6D). Application of the nonselective dopamine receptor
agonist ADTN (100 lM; in vehicle containing 100 lM L-AA)
or the D1 agonist SKF 38393 (50 lM) beginning at CT 13 in
the absence of light exposure, induced phase delays of
approximately 1 h (Figure 6D), which were signiﬁcantly lower
in amplitude than the phase delays produced by 1-h light
pulses (p , 0.01). Application of the D2 agonist quinpirole at
CT 13 did not reset retinal phase (Figure 6D).
GABA Negatively Regulates the Amplitude of Retinal
PER2::LUC Rhythms
In Figure 4G, we found that 1 mM GABA greatly
suppressed the amplitude of retinal PER2::LUC rhythms.
We further tested different concentrations of GABA on our
retinal explant cultures. Application of 0.1 mM GABA did not
Figure 6. Light Resetting of the Phase of Retinal PER2::LUC Rhythms Is
Mediated In Part through Dopamine D1 Receptors
(A and B) Phase changes of retinal PER2::LUC rhythms induced by 1-h
light pulses beginning at CT 13 (A) or CT 19.5 (B). Red traces show
rhythms from explants that received light; black traces are from paired
controls that were handled similarly, but did not receive light.
(C) Average data of light-induced phase shifts. Error bars from x-axis
show 6SEM for controls in which retinal explant cultures were taken out
from the LumiCycle and kept in darkness at 37 8C for 1 h.
(D) Phase changes of retinal PER2::LUC rhythms. Retinal explant cultures
were subjected to or treated with: column 1, 1-h light pulses (a
reproduction from [C]); column 2, pretreatment with the D1 receptor
antagonist SCH-23390 (D1 antag; 50 lM) for 15 min followed by 1-h light
pulses; column 3, pretreatment with SCH-23390 and the D2 antagonist
sulpiride (D2 antag; 50 lM) together for 15 min followed by 1-h light
pulses; column 4, the nonselective dopamine receptor agonist ADTN
(100 lM; in vehicle containing 100 lM L-AA); column 5, the D1 agonist
SKF 38393 (D1 ago; 50 lM); and column 6,the D2 agonist quinpirole (D2
ago; 50 lM). The 1-h light pulses or dopaminergic treatments were
initiated at CT 13. Phase change was calculated as in Figure 5. A single
asterisk (*) indicates p , 0.05; double asterisks (**) indicate p , 0.01;
Student’s t-test; n ¼ at least 3 for each treatment and for controls.
doi:10.1371/journal.pbio.0060249.g006
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Inner Retinal Clockobviously alter PER2::LUC rhythms compared with vehicle
(Figure 7A); however, at a higher concentration (0.5 mM),
GABA acutely suppressed the level of PER2::LUC biolumi-
nescence signals and greatly reduced the peak-to-trough
amplitude of PER2::LUC oscillations on subsequent circadian
cycles (Figure 7B). At 2 mM or 3 mM, GABA further inhibited
PER2::LUC luminescence levels and resulted in rapid damp-
ing of PER2::LUC rhythms (Figure 7C and 7D). Media changes
that removed GABA restored the damped oscillations (see
below). To further characterize the inhibitory action of
GABA on retinal rhythms, we calculated the ratio of the peak-
to-trough amplitude of the fourth circadian cycle (second
cycle after treatment) to the amplitude of the second cycle
(pretreatment control cycle, A4/A2). This ratio was plotted as a
function of GABA concentration (Figure 7E). The A4/A2 for
0.1 mM GABA was 0.82 6 0.06 (n ¼ 5), which was similar to
that for vehicle treatment (0.75 6 0.08; n ¼ 5). As GABA
concentration was increased, A4/A2 gradually decreased, and
at 3 mM GABA, most explants lacked clear rhythms, and the
few cycles that could be measured were of very low amplitude
(0.07 6 0.01; n¼7), indicating that GABA inhibits PER2::LUC
rhythmic amplitude in a dose-dependent manner. However,
GABA did not signiﬁcantly change the period of retinal
PER2::LUC rhythms compared with vehicle (s ¼ 23.80 6 0.16
h for 0.5 mM GABA, n¼6; s¼24.3360.22 h for 1 mM GABA,
n ¼ 7; and s ¼ 24.05 6 0.09 h for vehicle, n ¼ 5; p . 0.05 for
both comparisons to vehicle).
To test whether the inhibitory action of GABA is speciﬁc to
the retina, or common to other neural clock tissues, we
applied 1 mM or 3 mM GABA to mouse mPer2
Luc SCN
explants. GABA did not signiﬁcantly change the A4/A2 of SCN
PER2::LUC rhythms compared to vehicle (0.91 6 0.08 for 1
mM GABA; 0.86 6 0.07 for 3 mM GABA; 0.84 6 0.11 for
vehicle treatment; p . 0.05 for both; n ¼ 3 each; Figure S4);
neither did GABA have signiﬁcant effect on the period of
SCN PER2::LUC rhythms (s ¼ 23.56 6 0.26 h, 23.96 6 0.32 h,
and 23.63 6 0.23 h for 1 mM GABA, 3 mM GABA, and
vehicle, respectively; p . 0.05 for both comparisons to
vehicle; n ¼ 3 each). Therefore, GABA-induced inhibition of
ensemble PER2::LUC rhythms is retina speciﬁc.
GABAA and GABAC Receptors Mediate the Effects of GABA
on Retinal PER2::LUC Rhythms
Next, we characterized the receptors responsible for the
inhibitory action of GABA. GABA receptors are classiﬁed as
ionotropic, chloride-conducting GABAA and GABAC recep-
tors, or as metabotropic GABAB receptor. All three types of
GABA receptors are present in the mammalian retina [31].
When the GABAA receptor agonist muscimol (200 lM) or the
GABAC agonist cis-4-aminocrotonic acid (CACA; 50 lM) was
applied individually to the retinal explants, the amplitude of
retinal PER2::LUC rhythms was signiﬁcantly reduced com-
pared to that of vehicle-treated samples (see Table 1 for A4/A2
ratios of our GABA pharmacological treatments; Figure S5A
and S5C). However, the amplitude of PER2::LUC rhythms was
largely unaffected by the GABAB agonist baclofen (200 lM;
Figure S5B). When muscimol and CACA were applied
together, they mimicked the inhibition of 1 mM GABA on
retinal PER2::LUC rhythms (Figure 8A). Baclofen coapplied
with either muscimol or CACA, or baclofen coapplied with
both muscimol and CACA, did not enhance the inhibition of
the GABAA and GABAC agonists (Figure S5D–S5F). trans-4-
Aminocrotonic acid (TACA; 80 lM), an agonist for both
GABAA and GABAC receptors, inhibited luminescence
rhythms to a degree similar to 1 mM GABA (Figure 8B).
These results indicate that activation of both GABAA and
GABAC receptors is necessary to mimic fully the action of
GABA on retinal rhythms, with GABAB receptors playing no
apparent role, either alone or in combination with the other
receptors.
We further examined whether speciﬁc antagonists could
block the action of GABA. The inhibitory effect of 1 mM
GABA persisted when it was applied in the presence of the
GABAA receptor antagonist SR-95531 (40 lM) alone, the
GABAB receptor antagonist CGP-35348 (100 lM) alone, and
the GABAC receptor antagonist TPMPA (100 lM) alone
(Figure S6A–S6C). However, the effect of 1 mM GABA was
greatly attenuated by coapplication of SR-95531 and TPMPA
(Figure 8C). Coapplication of either SR-95531 with CGP-
35348, or TPMPA with CGP-35348 did not block the action of
1 mM GABA (Figure S6D and S6E). CGP-35348 also did not
signiﬁcantly enhance the blocking ability of SR-95531 and
TPMPA when it was coapplied with both antagonists (Figure
S6F). These results indicate that blockade of both GABAA and
GABAC receptors is necessary to attenuate GABA inhibition
of retinal rhythms with, again, no dependence on GABAB
receptors.
Figure 7. GABA Sets the Amplitude of Retinal PER2::LUC Rhythms in a
Dose-Dependent Manner
(A–D) Representative PER2::LUC bioluminescence traces recorded from
cultured mPer2
Luc retinal explants that received different doses of GABA
treatment. Bars indicate the duration of GABA treatment.
(E) Dose-dependent inhibitory action of GABA on the amplitude of
retinal PER2::LUC rhythms. The ratio of the peak-to-trough amplitude of
the fourth cycle to that of the second cycle (A4/A2) was plotted as a
function of the external GABA concentration. Data are represented as
mean 6 SEM (n ¼ at least 3 explants per point).
doi:10.1371/journal.pbio.0060249.g007
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generation, we next applied various GABA receptor antago-
nists to cultured mPer2
Luc retinal explants. When GABAA or
GABAC antagonists SR-95531 (40 lM) and TPMPA (100 lM)
were applied individually, each modestly increased the peak-
to-trough amplitude of luminescence rhythms (Figure S7A
and S7C), whereas application of the GABAB antagonist CGP-
35348 (100 lM) alone did not change the amplitude (Figure
S7B). However, antagonism of both GABAA and GABAC
receptors with SR-95531 and TPMPA signiﬁcantly increased
the peak-to-trough amplitude of retinal ensemble PER2::LUC
luminescence rhythms compared with vehicle (Figure 8D and
8E), indicating that endogenous GABA indeed suppresses the
amplitude of retinal PER2::LUC rhythms. Again, CGP-35348
did not enhance the effect of SR-95531 and TPMPA (Figures
4H, S7D, and S7E). Taken together, these pharmacological
studies indicate that endogenous retinal GABA reduces
PER2::LUC signals and the amplitude of molecular retinal
circadian rhythms through activation of both GABAA and
GABAC receptors.
Prolonged Application of GABA Stops the Retinal Clock
To further test whether GABAergic suppression of PER2::-
LUC luminescence rhythms results from an effect on the core
function of the retinal clock, we tested whether prolonged
application of GABA can halt the molecular oscillation of the
retinal clock. GABA (added to a ﬁnal concentration of 3 mM
in 1 ll of water vehicle) was applied to retinal cultures for
different durations (1, 7, 13, 19, 25, 31, 37, and 43 h), starting
at the beginning of the third cycle in vitro (Figure 9A and 9B).
We hypothesized that if retinal rhythms generation was
stopped by prolonged GABA application, and restored upon
washout, then the time of washout should predict the
subsequent phase of restored rhythms. In contrast, if the
observed suppression of PER2::LUC luminescence rhythms
during GABA application did not have an effect on the core
clock, but merely on luminescence output, then the phase of
restored rhythms should be predicted by the projected phase
of the baseline rhythm obtained prior to treatment. Figure
9C shows the peak times of retinal PER2::LUC rhythms
following GABA treatment and washout at the speciﬁed time
intervals. For retinas exposed to GABA for 19 h or greater,
the ﬁrst peak of the restored luminescence rhythm always
appeared ca. 22 h following GABA washout, with subsequent
peaks occurring approximately at 24-h intervals. The trend
lines of peak times show that the phase of restored rhythms is
indeed predicted by the time of washout, but not by projected
continuation of previous rhythms. In a control experiment, 1
ll of water vehicle was applied to retinal cultures for 37 h and
then the medium was changed, as in the GABA application
experiments. In this case, the ﬁrst peak of the ongoing
PER2::LUC rhythms occurred ca. 14 h after the media change,
not ca. 22 h after, as when GABA was washed out (n¼3). Thus,
GABA affects the retinal clock, not just its output, and its
Table 1. Summary of GABA Pharmacological Data






Vehicle H2O 0.68 6 0.05 N/A p , 0.001 5




Muscimol (200 lM) 0.46 6 0.06 p , 0.05 p , 0.05 4
Baclofen (200 lM) 0.63 6 0.08 p . 0.05 p , 0.01 4
CACA (50 lM) 0.40 6 0.05 p , 0.01 p , 0.05 4
Muscimol þ baclofen 0.54 6 0.07 p . 0.05 p , 0.01 5
Muscimol þ CACA 0.30 6 0.05 p , 0.001 p . 0.05 5
Baclofen þ CACA 0.36 6 0.03 p , 0.001 p , 0.05 5
TACA (80 lM) 0.29 6 0.05 p , 0.001 p . 0.05 4




GABA þ SR-95531 (40 lM) 0.33 6 0.08 p , 0.01 p . 0.05 4
GABA þ CGP-35348 (100 lM) 0.26 6 0.05 p , 0.001 p . 0.05 4
GABA þ TPMPA (100 lM) 0.32 6 0.10 p , 0.01 p . 0.05 4
GABA þ SR-95531 þ CGP-35348 0.35 6 0.09 p , 0.05 p . 0.05 5
GABA þ SR-95531 þ TPMPA 0.77 6 0.11 p . 0.05 p , 0.01 5
GABA þ CGP-35348 þ TPMPA 0.28 6 0.05 p , 0.001 p . 0.05 5
GABA þ SR-95531 þ CGP-35348 þ TPMPA 0.68 6 0.06 p . 0.05 p , 0.001 5
GABA receptor
antagonists
SR-95531 (40 lM) 0.78 6 0.08 p . 0.05 p , 0.001 4
CGP-35348 (100 lM) 0.61 6 0.08 p . 0.05 p , 0.01 4
TPMPA (100 lM) 0.81 6 0.07 p . 0.05 p , 0.001 4
SR-95531 þ CGP-35348 0.72 6 0.14 p . 0.05 p , 0.01 4
SR-95531 þ TPMPA 1.19 6 0.11 p , 0.01 p , 0.001 5
CGP-35348 þ TPMPA 0.81 6 0.10 p . 0.05 p , 0.001 4
SR-95531þ CGP-35348 þ TPMPA 1.01 þ 0.10 p , 0.05 p , 0.001 4
Concentration of each drug in coapplication is the same as in individual application; A4/A2 values are shown as means 6 SEM.
N/A, not applicable.
doi:10.1371/journal.pbio.0060249.t001
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to stop the molecular clock mechanism at a certain phase.
GABA Acts Posttranscriptionally through Membrane
Polarization and Casein Kinase
To determine the mechanisms by which GABA suppressed
retinal PER2::LUC expression and rhythmicity, we ﬁrst
quantiﬁed Per1, Per2, Clock, and Bmal1 mRNA levels 8 h after
3 mM GABA treatment using quantitative real-time PCR.
Interestingly, GABA did not change the mRNA levels of Per2
and Clock, but did increase the mRNA levels of Per1 and Bmal1
(Figure 10A). Therefore, the substantial reduction in PER2::-
LUC expression upon GABA treatment is likely due to
posttranscriptional regulation.
The ﬁnding that GABA acts on the retinal PER2::LUC
rhythms through ionotropic, Cl
 -conducting receptors sug-
gested that GABAergic modulation of the clock could be
mediated by membrane hyperpolarization or, in the case of
prolonged GABA application, by alteration of membrane
ionic gradients leading to tonic depolarization [56]. Depola-
rization with elevated K
þ media (4 mM) during 1 mM GABA
application partially restored the rhythmic amplitude of
PER2::LUC expression (A4/A2 ¼ 0.70 6 0.04 for vehicle, 0.20
6 0.05 for GABA, and 0.45 6 0.07 for 4 mM K
þþGABA; n¼5
each; Figure 10B and 10C), indicating that GABA acts in part
through membrane hyperpolarization. Prolonged application
of high K
þ alone modestly increased the amplitude of
PER2::LUC rhythms (A4/A2 ¼ 0.90 6 0.10; n ¼ 5; Figure
10D), indicating that the inhibitory effect of GABA on retinal
PER2::LUC rhythms is not due to tonic depolarization. The
effect of GABA is not mediated through the simple cessation
of neuronal spiking due to membrane hyperpolarization,
because blocking neuronal spiking with TTX (1 lM) did not
affect retinal PER2::LUC rhythms (A4/A2 ¼ 0.67 6 0.09; n ¼ 5;
Figure 3G).
Depolarization with elevated K
þ media in the presence of
GABA only partially rescued the amplitude of retinal
PER2::LUC rhythms, indicating that other mechanisms
contribute to the inhibitory action of GABA. The epsilon
and delta isoforms of CKI are important regulators of PER
protein stability that phosphorylate PER2 and target it for
Figure 8. GABA Acts through GABAA and GABAC Receptors
(A) Coapplication of the GABAA receptor agonist muscimol (200 lM) and
the GABAC receptor agonist CACA (50 lM) to retinal explants mimicked
the inhibitory action of 1 mM GABA on retinal PER2::LUC rhythms.
(B) The GABAA and GABAC receptor agonist TACA (80 lM) inhibited
PER2::LUC expression rhythms in a way similar to 1 mM GABA.
(C) The GABAA receptor antagonist SR-95531 (40 lM) and the GABAC
receptor antagonist TPMPA (100 lM) greatly attenuated the action of
GABA when they were coapplied with 1 mM GABA.
(D) Coapplication of SR-95531 (40 lM) and TPMPA (100 lM) increased
the amplitude of retinal PER2::LUC rhythms.
Bars in (A–D) indicate the duration of treatment.
(E) Blockade of GABAA and GABAC receptors with 40 lM SR-95531 and
100 lM TPMPA (solid line, filled circles) significantly increased the
amplitude of retinal PER2::LUC rhythms compared with vehicle-treated
explants (dashed line, open circles). Mean peak-to-trough amplitudes
(6SEM, n¼5; normalized to the amplitude of the second circadian cycle)
of retinal PER2::LUC rhythms were plotted as a function of PER2::LUC
cycle number in the LumiCycle. A single asterisk (*) indicates p , 0.007,
post hoc t-test with Bonferroni-corrected a ¼ 0.007.
doi:10.1371/journal.pbio.0060249.g008
Figure 9. Prolonged Application of GABA Stops the Retinal Clock
(A and B) Representative retinal explant cultures that received 1 h (A) or
43 h (B) of 3 mM GABA treatment. GABA treatment was started at the
beginning of the third circadian cycle. Bars indicate the duration of GABA
treatment. Treatment was terminated by fresh media change.
(C) Shown are PER2::LUC expression peaks following GABA washout.
Four retinal explants were sampled for each duration of GABA treatment.
Bars indicate the duration of GABA treatment. Open circles, filled
triangles, open triangles, filled squares, open squares, and filled
diamonds indicate first, second, third, fourth, fifth, and sixth peak times,
respectively, following GABA washout. Time 0 corresponds to the start of
GABA treatment. In the samples with 19–43 h of GABA application, the
first peaks appeared ca. 22 h after media change, and the reinitiated
rhythms were phase locked to the termination of the GABA pulse,
indicating that prolonged application of high dose of GABA stops retinal
ensemble PER2::LUC rhythms.
doi:10.1371/journal.pbio.0060249.g009
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Inner Retinal Clockubiquitin-mediated proteasomal degradation [57]. In addi-
tion, casein kinases associate with GABAA and GABAC
receptor subunits [58,59]. To test whether casein kinases are
involved in the inhibitory effect of GABA on PER2::LUC
levels and retinal rhythms, we applied the casein kinase
inhibitor CKI-7 (50 lM) along with 1 mM GABA to mPer2
Luc
retinal explant cultures. CKI-7 partially rescued rhythmic
amplitude in the presence of GABA (A4/A2 ¼ 0.35 6 0.03 for
CKI-7þGABA vs. 0.20 6 0.05 for GABA; p , 0.05; n¼5 each;
Figure 10E). When KCl (4 mM) and CKI-7 (50 lM) were
coapplied with 1 mM GABA, the rescue of rhythmic
PER2::LUC amplitude was complete (A4/A2 ¼ 0.93 6 0.15; n
¼ 4; Figure 10F). When applied alone, CKI-7 did not
signiﬁcantly change the amplitude of PER2::LUC rhythms;
however, it substantially lengthened retinal free-running
period from 24.05 6 0.09 h (n ¼ 5) to 25.77 6 0.38 h (n ¼ 6;
p , 0.005; Figure 10G). Taken together, these results suggest
that GABA acts, in part, by stimulating casein kinase to
suppress PER2 levels.
Discussion
In the present study, we developed a retinal explant culture
protocol that enables the assay of circadian clock gene
expression rhythms in real time from isolated, intact mPer2
Luc
mouse retinas. Using this protocol, we characterized retinal
PER2::LUC expression rhythms, localized their source within
the retinal layers, examined the inﬂuence of multiple retinal
neurotransmitters, as well as sodium-dependent action
potentials and cx36-containing gap junctions, and charac-
terized light resetting of retinal oscillations. We found that
isolated mouse retinas exhibited sustained, endogenous
circadian rhythms in PER2::LUC expression localized pri-
marily to the inner nuclear layer of the mouse retina, the
generation of which was independent of many forms of
signaling from photoreceptors and ganglion cells, or major
forms of neural communication within the inner nuclear
layer. Endogenous retinal dopamine and GABA, although not
necessary for retinal PER2::LUC rhythms generation, were
found to play key roles in regulating the retinal circadian
clock: mediating light resetting of rhythmic phase and
inﬂuencing the amplitude of retinal PER2::LUC rhythms,
respectively.
Culture of Mouse Retina
Information regarding the mechanisms of the mammalian
retinal clock has been limited by the challenge of long-term
culture of the mammalian retina and the interpretational
caveats imposed by using melatonin or dopamine neuro-
chemical output rhythms as proxies for observing the clock
mechanism. The protocol we have developed here, a
modiﬁcation of the explant culture method for SCN
luminescence recording [60], allows continuous readout of
the rhythmic abundance of a putative molecular component
of the circadian clock mechanism, PER2 protein, as bio-
luminescence intensity emitted by isolated, intact mouse
retinal explants. Within our preparations, all layers of the
retina were anatomically intact, and the retinas exhibited
robust circadian rhythms of PER2::LUC expression as well as
functional light responses in the form of phase resetting. A
key empirical ﬁnding in developing this culture protocol was
that incubation of the retina in bicarbonate-buffered
medium for the ﬁrst 24 h in vitro greatly enhanced the
amplitude and sustainability of retinal PER2::LUC rhythms.
The precise mechanism by which the transition through
bicarbonate-based medium preserves retinal rhythmicity is
unknown; however, bicarbonate balance has wide-ranging
effects on retinal physiology, and increased bicarbonate
Figure 10. GABA Acts Posttranscriptionally through Membrane Polar-
ization and Casein Kinase
(A) Shown are relative mRNA abundance of Per1, Per2, Clock, and Bmal1
in retinal explants 8 h after treatment with 3 mM GABA (black) or vehicle
(grey) started at the beginning of the third circadian cycle. Clock gene
mRNA levels were normalized to the mRNA levels of GAPDH. The
average mRNA levels of vehicle-treated samples were set to 1.0. Data are
presented as means 6 SEM (n ¼ 4). GABA did not significantly change
the transcript levels of Per2 and Clock, while significantly increased the
transcript levels of Per1 and Bmal1. A single asterisk (*)indicates p , 0.05;
double asterisks (**) indicate p , 0.01; Student’s t-test.
(B) GABA (1 mM) greatly suppressed retinal PER2::LUC rhythms.
(C) Depolarization with elevated K
þ (4 mM) partially blocked the
inhibitory effect of GABA (1 mM) on retinal PER2::LUC rhythms.
(D) Prolonged application of KCl (4 mM) modestly increased rhythmic
PER2::LUC amplitudes.
(E) Inhibition of casein kinase activity with CKI-7 (50 lM) partially rescued
the inhibitory action of 1 mM GABA on retinal PER2::LUC rhythms.
(F) KCl (4 mM) and CKI-7 (50 lM) greatly rescued the inhibitory action of
GABA (1 mM) on retinal PER2::LUC rhythms when they were co-applied
with GABA.
(G) When CKI-7 (50 lM) was applied alone, it lengthened the period of
retinal PER2::LUC rhythms.
Bars in (B–G) indicate the duration of treatment.
doi:10.1371/journal.pbio.0060249.g010
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amplitude of circadian rhythms in photoreceptor disc
shedding in amphibian retinas [61].
An Inner Nuclear Layer Retinal Clock
Imaging of PER2::LUC luminescence signals from retinal
vertical slice cultures of both B6C3 and C57BL/6J mice
showed that PER2::LUC rhythms were predominantly local-
ized to the inner nuclear layer of the retina, which contains
the nuclei of retinal horizontal, bipolar, and amacrine cells.
The pattern of PER2::LUC expression in the current study is
consistent with previous single-cell RT-PCR and in situ
hybridization studies demonstrating concentration of clock
gene transcripts in the inner nuclear layer of the mouse
[42,43,62], and immunocytochemistry studies showing pre-
dominant localization of PER1, PER2, and CLOCK proteins
in the inner nuclear layer as well [13,42]. Localization of
rhythmic PER2::LUC expression to the inner nuclear layer is
consistent with the persistence of PER2::LUC rhythms in
photoreceptor-degenerate mouse retinas [43], and with the
persistence of Per2 rhythms in photoreceptor-degenerate
RCS retinas [63]. The fact that disruption of communication
through glutamate, sodium-dependent action potentials, and
cx36-containing gap junctions did not disrupt retinal
rhythms further suggests that communication through
ganglion cells is not necessary. The wide distribution of
PER2::LUC expression across the inner nuclear layer suggests
that multiple inner nuclear layer cell types are sources for the
rhythmic PER2::LUC signal and are likely participants in the
inner retinal clock mechanism. Cell-type–speciﬁc mapping of
coordinate expression of the core circadian clock genes has
demonstrated that signiﬁcant proportions of horizontal, rod
bipolar, and dopaminergic amacrine neurons of the inner
nuclear layer express all six core clock genes and thus are
candidate cell types for self-sustained circadian rhythms
generation [43].
Although, our results suggest that the inner nuclear layer of
the intact mouse retina contains a circadian clock, our study
does not preclude the potential for circadian rhythms
generation in the photoreceptor or ganglion cell layers.
Indeed, Tosini et al. [64] have recently reported gene rhythms
from photoreceptor layers isolated from rat retinas that carry
a transcriptional transgenic reporter for Per1, rather than the
knockin fusion protein reporter for PER2 used here.
Cell Communication and Rhythms Generation
Our ﬁndings support cell-autonomous rhythms generation
in the inner nuclear layer clock rather than rhythms
generation as a network property dependent upon cell
communication. None of the major neurotransmitter systems
in photoreceptors (melatonin and glutamate), ganglion cells
(glutamate), or the inner nuclear layer (dopamine, acetylcho-
line, GABA, glycine, and glutamate) was required to support
generation of retinal circadian PER2::LUC rhythms, nor was
intercellular communication through sodium-dependent
action potentials and cx36-containing gap junctions,
although dopamine and GABA exhibited important effects
on retinal PER2::LUC rhythms. A question that arises for
interpretation of these negative ﬁndings regarding cellular
communication is the duration over which pharmacological
treatments were effective in vitro. For GABA agonists and
antagonists, it is clear that they are effective for at least 7 d
(Figures 4, 7, and 8). For many other target transmitter
systems, we have included genetic or chemical alternative
tests that mitigate against this concern. For example,
melatonin has been depleted genetically, as well as manipu-
lated pharmacologically; dopamine has been depleted chemi-
cally, as well as manipulated pharmacologically; and gap
junctional communication through the principal neural
connexin, cx36, has been lesioned genetically to complement
pharmacological disruption of electrical synapses. All of these
alternative manipulations gave negative results consistent
with the pharmacology. Blockade of sodium-dependent
action potentials with TTX has previously been shown to be
effective in disrupting circadian rhythms in the SCN cultured
under similar conditions for several days [50,65]. In addition,
TTX blockade of sodium-dependent action potentials itself
would have signiﬁcantly reduced the spike-mediated release
of GABA, glycine, glutamate, acetylcholine, and dopamine by
amacrine and ganglion cells of the inner retina, reinforcing
the negative ﬁndings with the pharmacological blockers
speciﬁc to each of these transmitter systems. Thus, we cannot
exclude all possibility that these transmitter systems contrib-
ute to circadian rhythms generation in the retina; however,
the consistent results we have obtained with overlapping
types of treatments suggest that these negative results are
robust. We also cannot rule out the possibility that multiple
transmitter systems play redundant roles, or the possibility
that some untested neurochemical signals are critical, but our
data do exclude previous models of retinal circadian
organization in which a limited population of cells using
one of the modulatory neurotransmitters acts as a pacemaker
for all retinal neurons, such as the 500 dopaminergic
amacrine cells in each retina driving all other retinal
oscillator cells through dopamine secretion, or the photo-
receptors driving all other retinal oscillators through
melatonin release [38].
Regulation of the Inner Retinal Circadian Clock by Light
and Dopamine
It is well established that dopamine and melatonin are
important neurochemical messengers of the retinal circadian
clock that act at multiple sites within the retinal circuitry to
shape retinal function into ‘‘day’’ and ‘‘night’’ states
[38,39,66,67]. Our results distinguish the roles of these
neurotransmitters in retinal circadian organization, indicat-
ing that whereas dopamine has the additional role of
regulating the phase of the core clock mechanism, melato-
nin’s role is primarily that of an output messenger of the
clock. Our ﬁnding that PER2::LUC rhythms persist in C57BL/
6J mouse retinas with genetically blunted melatonin produc-
tion and following pharmacological manipulation of melato-
nin signaling is consistent with previous studies showing that
melatonin is not required for circadian photoreceptor disk
shedding in constant darkness [4], and that photoreceptors,
the primary source of retinal melatonin, are not required for
retinal PER2::LUC rhythms generation [43]. In addition, in
the present study, neither manipulation of melatonin nor
blockade of MT1 receptors signiﬁcantly altered the phase of
retinal PER2::LUC rhythms. Taken together, these results
suggest that melatonin is an output messenger of the clock,
which can inﬂuence dopamine release and other aspects of
retinal physiology, but which does not directly affect or feed
back onto the molecular clock mechanism.
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retinal clock mechanism. Stimulation of dopamine D1
receptors reset the phase of retinal PER2::LUC rhythms,
whereas blockade of dopamine D1 receptors reduced the
amplitude of phase delays induced by light pulses given in the
early subjective night. These effects on circadian phase
demonstrate that retinal dopamine inﬂuences the core clock
mechanism of mammalian retinas. Our ﬁndings suggest D1
dopamine receptors are key to the action of dopamine on the
retinal circadian pacemaker, whereas D2 receptors have been
suggested to play a role in light-induced Per gene induction
by dopamine [68]. Both studies suggest that dopamine targets
retinal cell types in the inner nuclear layer clock to reset the
retinal circadian oscillator. The potential targets of phase
resetting include multiple cell types that are the primary sites
of D1 receptor expression in the inner nuclear layer:
horizontal, AII amacrine, and bipolar cells [69]. The lack of
phase setting of the inner retinal oscillator by the D2/D4
agonist quinpirole and melatonin suggests that photorecep-
tors and melatonin do not participate in the dopaminergic
resetting process, as D4 receptors are expressed predom-
inantly in retinal photoreceptors where they inﬂuence
melatonin synthesis [69]. The D1-dependent resetting mech-
anism, which targets neurons of the inner nuclear layer, is
distinct from dopamine-mediated light resetting of amphib-
ian retinal melatonin rhythms, which involves D2-like
receptors on photoreceptor cells [70,71].
Our demonstration of light resetting of in vitro retinal
PER2::LUC rhythms is consistent with previous ﬁndings that
the melatonin secretion rhythms of the mouse retina could be
synchronized to light cycles in vitro [17] . All retinal
photoreceptive cell types—rods, cones, and melanopsin
ganglion cells—are anatomically intact in the retinal explants
we used, and thus could contribute to the circadian light
responses we recorded. In this regard, it is interesting to note
that dopaminergic amacrine neurons are light responsive [72]
and that a subpopulation of them exhibit sustained light
responses driven by melanopsin-expressing intrinsically
photoreceptive ganglion cells in a novel intraretinal photic
pathway [73]. Thus, melanopsin ganglion cells may contribute
to the entrainment of both retinal and SCN neural oscillators.
Based on our results, we propose that endogenous retinal
dopamine serves to synchronize the inner retinal circadian
clock to the external light/dark cycle. In vivo, retinal
dopamine release is rhythmic, exhibiting a peak near dawn
each day, due to both circadian and light-driven regulation of
retinal dopamine [74]. Light increases the activity of retinal
tyrosine hydroxylase, the key enzyme in dopamine synthesis,
within 15 min of light onset [75], and evokes a sharp burst of
dopamine synthesis and utilization within 30 min of light
onset [76]. On a molecular level, dopamine mediates acute
light induction of the Per1 gene in the mouse retina [68] and
resets the Xenopus photoreceptor clock through induction of
xPer2 [70,71]. The phase dependence of dopamine-induced
phase shifts we have observed corresponds with the likely
phase-resetting response to light, with phase advances
induced in the early subjective day and phase delays in the
early subjective night. Phase delays induced by light pulses in
the early subjective night were signiﬁcantly reduced by
blockade of dopamine D1 receptors. The circuitry of
mammalian retinal dopaminergic amacrine cells [72,73], the
molecular action of dopamine on retinal clock genes [68], and
our direct demonstration of dopamine effects on clock phase
and light resetting of retinal clock phase, all indicate that
dopamine transmission likely mediates light entrainment of
the inner retinal mammalian circadian clock through its
action on Per gene levels and rhythms. Importantly, light-
induced phase shifts were not completely blocked by D1
antagonists and dopamine agonists could not mimic the full
amplitude of light-induced phase shifts, suggesting that other
neurotransmitters are also involved in the light entrainment
process.
In addition to setting the phase of the retinal clock,
dopamine is a key output of the retinal clock, inducing many
of the functional changes in retinal neurons and circuits that
deﬁne the ‘‘day’’ state of retinal function, such as cone-
dominated processing in visual circuits and ERG amplitude
[13,66,77], and mediating circadian rhythms in behaviorally
measured visual sensitivity [78]. Thus, retinal dopamine
apparently plays dual roles in the circadian organization of
the retina, serving as an output signal that mediates many of
the physiological, morphological, and trophic rhythms in the
retina, as well as an input signal to regulate the phase of the
molecular clock mechanism in relation to the external light/
dark cycle. As both a key input to and output from the
mammalian retinal clock, dopamine plays a central role in
retinal circadian organization and is an important point for
mechanistic intervention in ocular processes and pathologies
regulated by the circadian clock.
GABA and Retinal PER2::LUC Rhythms
In the current study, we found that GABAA and GABAC
receptor blockade signiﬁcantly increased the amplitude of
retinal PER2::LUC rhythms, whereas application of exoge-
nous GABA damped rhythmic amplitude, and with prolonged
application, stopped the retinal circadian clock. The high
concentrations of exogenous GABA (.100 lM) necessary to
modulate retinal PER2::LUC rhythms in these experiments
are likely due to uptake by high-afﬁnity GABA transporters
present on a range of retinal neurons, as well as on retinal
Mu ¨ller cells [79]. Previous electrophysiological experiments
have demonstrated, for example, that application of 100 lM
GABA produces near-maximal effects on isolated retinal
ganglion cells, but higher concentrations are necessary to
produce detectable effects in retinal slice preparations [80].
Our ﬁnding that the effects of GABA can be mimicked or
blocked by GABAA and GABAC receptor agonists and
antagonists indicates that the effects of GABA on retinal
PER2::LUC rhythms are receptor mediated and speciﬁc.
Our data establish that GABAergic regulation is a common
mechanism across neural circadian clocks because blockade
of GABA receptors in SCN explants also increases Per1::luc
rhythmic amplitude [65], and application of GABA resets the
phase of spike frequency rhythms in isolated SCN neurons
[81]. However, the ability of exogenous GABA to suppress
substantially PER2::LUC rhythms is unique to the retina, as
similar experiments with SCN slices do not yield similar
results. The increased effectiveness of GABA as a modulator
of retinal PER2 expression is likely due to the speciﬁc retinal
expression of the GABAC receptor, which engenders non-
desensitizing responses and prolongs greatly the effectiveness
of any GABA stimulation [82–84].
The inhibitory action of GABA on the amplitude of retinal
PER2::LUC rhythms could act through damping of circadian
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ronizing individual oscillators, and differentiating these
mechanisms will require single-cell resolution studies of
retinal circadian rhythms. A functional consequence of
reducing rhythmic amplitude, predicted by limit cycle models
of circadian oscillators, is to increase sensitivity to phase-
resetting stimuli. Thus, a potential role of GABA in neural
circadian oscillators is to enhance the effectiveness of
endogenous phase-communicating substances, such as dop-
amine in the retina [70], or vasoactive intestinal polypeptide
(VIP) and gastrin-releasing peptide (GRP) in the SCN [85,86],
in resetting the rhythms of neuronal oscillators by limiting
the amplitude of the intracellular molecular clock oscilla-
tions.
On a mechanistic level, our data suggest that GABA acts to
suppress the amplitude of retinal PER2::LUC rhythms
through membrane hyperpolarization and casein kinase
activation. The mechanism by which GABA may stimulate
retinal casein kinases is unknown at this point. CKI has been
shown to physically associate with GABAA receptors in a
rhythmic manner in the SCN [58], and CKII has been shown
to phosphorylate GABAC receptor subunits [59]. These types
of physical associations between GABA receptors and casein
kinases have been assumed to be for receptor modulation,
but could provide a link between persistent activation of
GABA receptors and activation of casein kinases as well. It is
noteworthy that the circadian association between CKIe–
CKId and GABAA receptors in the rat SCN peaks at CT 6–7
[58], when GABA content in the SCN is high [87] and PER
levels are low [88,89], and then drops to low levels in early
subjective night when PER levels peak. This may imply a novel
clock regulatory mechanism in which PER and GABA
receptors compete for association with casein kinases. It will
be of importance to test this hypothesis in the mouse retina,
where GABA exhibits signiﬁcant effect on PER2::LUC
rhythms. Alternatively, casein kinases are regulated by
protein phosphatases and by metabotropic glutamate recep-
tors [90,91], and perhaps persistent GABA stimulation alters
these pathways. It will be of interest in the future to elucidate
more fully the mechanistic relationship of GABA to casein
kinase and its effect on the retinal clock.
GABA and Retinal Circadian Clock Organization
Our ﬁnding that GABA plays key roles in the retinal
circadian clock draws attention to GABAergic neurons as
sources of these retinal circadian signaling molecules and
potential sites of rhythms generation. The full complement of
core clock genes is expressed in GABAergic horizontal cells
and dopaminergic amacrine cells, which also express GABA
[43]. In addition, transcription of the Per1 clock gene has been
shown to occur in most GABAergic amacrine cells, and
rhythmically in the dopaminergic and nitric-oxide synthase
(NOS)-positive subtypes of GABAergic amacrine cells [42,92].
Thus, there is a strong correlation of core clock gene
expression within GABAergic retinal neurons, suggesting a
molecular basis for circadian regulation of this neuro-
transmitter.
Retinal GABA turnover rate and release show rhythmic
variations under constant darkness condition, with their
levels higher in the subjective night [21]. Furthermore, GABA
increases melatonin content in a dose-dependent manner in
the hamster retina [93]. Our results suggest that GABA could,
through membrane hyperpolarization and activation of
casein kinase, stimulate the degradation of accumulated
PER proteins on the falling phase of their rhythm (which
roughly corresponds to the night state), acting to remove
feedback inhibition on Per transcription and thereby prepar-
ing retinal oscillators for transcriptional activation that
characterizes the ‘‘day’’ state. Importantly, GABA is not
acting merely through suppression of dopamine release, as
dopamine depletion does not mimic the effects of GABA.
Taken together, these data are consistent with the notion that
one role of GABA in the retinal circadian clock is to function
as an analog for darkness and enforce the ‘‘night’’ state in the
mammalian retina, along with melatonin.
Our ﬁnding that the GABAC receptor is a critical co-
mediator of GABA inﬂuence on retinal PER2::LUC rhythms
suggest roles for neurons in the outer half of the retina in
circadian clock function. The GABAC receptor has a
restricted distribution in the mammalian retina, with the
primary site of expression on bipolar cell synaptic terminals
in the inner plexiform layer where it mediates recurrent
feedback from GABAergic amacrine cells [94], and a
secondary site of expression in mouse cone photoreceptors
[95]. Thus, the balance of results suggests that retinal bipolar
cells, some of which coordinately express all the core clock
genes [43], and perhaps photoreceptors, are important
targets of GABAergic regulation in the retinal circadian
clock network. Convincing evidence for the presence of
GABAC receptors on rod photoreceptors and horizontal,
amacrine, and ganglion cells in the mammalian retina is still
lacking; however, GABAA receptors may mediate the action
of GABA on these cell types, because the GABAA receptor
agonist muscimol alone partially reduced rhythmic PER2::-
LUC amplitudes (Figure S3A), and GABAA receptors have
been detected in these retinal cell types [31].
Model for the Mouse Retinal Circadian Clock Organization
In summary, the present data are consistent with the
hypothetical model shown in Figure 11 for circadian
organization of the mammalian retina in which GABAergic
and dopaminergic neurons play key roles through rhythmic
secretion of dopamine and GABA, and the subsequent
molecular actions of dopamine and GABA on PERs, via
transcriptional activation and degradation. In this model,
dopamine, which exhibits both circadian and light-induced
elevation in the day phase [19,75], reinforces the rising phase
of Per molecular rhythms during the day through up-
regulation of Per genes via the mitogen-activated extracel-
lular signal-regulated kinase (ERK) kinase (MEK) and the
cAMP-responsive element-binding protein (CREB) binding
protein (CBP) [68]. In terms of phase resetting, increasing
dopaminergic stimulation on the initial rising phase of the
PER2 rhythms, corresponding to the early day, resulted in
phase advances, whereas increasing dopaminergic stimula-
tion near the peak in PER2 expression, corresponding to the
early night, resulted in phase delays. We propose that light
stimulation of dopaminergic neurons through M-cones and
ON bipolar cells, as well as intrinsically photosensitive retinal
ganglion cells (ipRGCs) [73] at these phases would act to
synchronize molecular retinal circadian rhythms to the light/
dark cycle. In contrast, retinal GABA exhibits elevated
turnover and release at night [21], perhaps from excitatory
input from OFF bipolar cells to GABAergic amacrine cells,
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PER proteins through casein kinase activation, acting to
remove feedback inhibition on Per transcription, and thereby
preparing retinal oscillators for transcriptional activation in
the next ‘‘day’’ state. GABA might also facilitate the
molecular resetting effects of dopamine through negatively
regulating the amplitude of retinal PER rhythms. Thus, GABA
transmission acts to reinforce the ‘‘night’’ state of the retinal
clock. The idea that GABA serves as a ‘‘dark’’ signal is
consistent with previous ﬁndings that GABA and the GABAA
receptor agonist muscimol cause dark-adaptive retinomotor
movements in the Xenopus and ﬁsh retinas [96,97] and that
GABA suppresses tyrosine hydroxylase activity [98] and
inhibits dopamine release [49].
Future studies employing our in vitro retinal explant
culture system and other strategies can test our working
hypothesis regarding the organization of the mammalian
retinal circadian clock, and further elucidate the cellular and
molecular mechanisms of retinal circadian clocks and their
inﬂuence on visual function. The highly ordered and well-
characterized property of retinal circuitry will facilitate




Luc knockin mice, which initially were on a 129SvEv
X C57BL/6J genetic background [44], were maintained as a
continuous backcross to C57BL/6J for 13 generations. The resulting
mPer2
Luc mice were crossed with C3H rd1 mice (The Jackson
Laboratory) to produce mPer2
Luc mice that are heterozygous for the
rd1 gene mutation and are genetically capable of producing
melatonin. Unless otherwise speciﬁed, the mice used in the experi-
ments were B6C3F1 mPer2
Luc mice. All animal use was conducted in
accordance with the guidelines of the Vanderbilt University Animal
Care Division and the Association for Research in Vision and
Ophthalmology (ARVO) Statement for the Use of Animals.
Retinal explant culture. mPer2
Luc mice 28–60 d of age were killed at
approximately ZT 4 during the day phase (4 h after lights on in the
mouse colony). Eyes were enucleated and placed in Hank’s balanced
salt solution (HBSS; Invitrogen). Retinas were isolated and cut into
two pieces. Each piece of retina was placed with the ganglion cell
layer up on Millicell culture membrane (Millipore) and gently
ﬂattened with two end-blunted glass pipettes. The membrane was
ﬁrst transferred to 1.0 ml of neurobasal medium (Invitrogen)
supplemented with 2 mM L-glutamine (Sigma-Aldrich), 2% B27
(Invitrogen), 25 units/ml penicillin, and 25 lg/ml streptomycin
(Invitrogen), incubated in 5% CO2 incubator at 37 8C for 24 h, and
then transferred to 1.0 ml of medium 199 (Sigma-Aldrich) supple-
mented with 0.7 mM L-glutamine, 4 mM sodium bicarbonate (Sigma-
Aldrich), 10 mM Hepes (Sigma-Aldrich), 20 mM D-glucose (Sigma-
Aldrich), 2% B27, 0.1 mM beetle luciferin (Promega), 25 units/ml
penicillin, and 25 lg/ml streptomycin. Bioluminescence was measured
with a LumiCycle (Actimetrics). Cultures were maintained at 37 8C.
LumiCylce (Actimetrics) software was used to calculate peak-to-
trough amplitude, and ClockLab software (Actimetrics) was used to
determine the peak time (maximum phase) of PER2::LUC rhythms
from the raw data.
SCN explant culture. At approximately ZT 4, mPer2
Luc knockinmice
were killed by cervical dislocation, the brains rapidly extracted
following decapitation and immediately placed in cold HBSS. Coronal
brain sections (250-lm thickness) were cut with a Vibratome (World
Precision Instruments), transferred to cold HBSS, and sorted under a
dissecting microscope. Slices containing the SCN were trimmed to
rectangles 3 3 3 mm with a pair of scalpels, and then cultured on
Millicell culture membranes with 1.0 ml of DMEM (Sigma), supple-
mented with 4 mM sodium bicarbonate, 10 mM Hepes, 20 mM D-
glucose, 2% B27, 0.1 mM beetle luciferin,25 units/ml penicillin, and 25
lg/ml streptomycin. Bioluminescence was continuously measured
with a LumiCycle. Cultures were maintained at 37 8C.
Vertical retinal slice imaging. Freshly isolated retinas were
attached tightly to Millipore membrane ﬁlters, with the ganglion cell
Figure 11. Model for the Circadian Clock Organization in the Mouse Retina
Dopaminergic amacrine cells (red) and GABAergic cells (blue) reinforce the autonomously generated ‘‘day’’ and ‘‘night’’ states of oscillator cells (yellow)
in the inner nuclear layer (INL) through rhythmic secretion of dopamine and GABA, respectively. Dopamine transmission stimulated by excitatory light
input from M-cones via ON bipolar cells and/or from intrinsically photosensitive retinal ganglion cells (ipRGCs) likely acts to phase-shift retinal circadian
oscillators and reinforce the rising phase of the ‘‘day’’ state of the retinal clock. At night (i.e., molecularly, roughly the falling phase of PER protein
rhythms), excitatory input from OFF bipolar cells enhances the activity of GABA, which suppresses rhythmic amplitude of PER oscillations through the
GABAA and GABAC receptors and facilitates the molecular resetting effects of dopamine. In addition, endogenous GABA is proposed to reinforce the
falling phase of PER rhythms through fostering degradation of accumulated PER protein.
doi:10.1371/journal.pbio.0060249.g011
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Inner Retinal Clocklayer facing the ﬁlters, sliced into 150-lm-thick sections with a tissue
slicer (Stoelting), transferred onto Millicell membrane inserts, and
cultured with 1.0 ml of neurobasal medium, and then incubated in
5% CO2 incubator at 37 8C for 1–2 d. Immediately before imaging, 0.1
mM beetle luciferin was added to the culture medium. Images of 30-
min exposure duration were collected using a 203objective (NA 0.35)
coupled directly to a PIXIS camera system (Princeton Instruments)
cooled to 70 8C. Signal-to-noise ratio was improved by 232 binning
of pixels. Data were analyzed with Metamorph software (Molecular
Devices).
Immunocytochemistry. Retinal explant whole mounts were ﬁxed in
phosphate-buffered saline (PBS) containing 4% paraformaldehyde
(PFA), blocked with 1% bovine serum albumin (BSA) and 0.3%
Triton X-100 in 0.1 M PBS for 2 h, and then incubated in the primary
antibodies at 4 8C for 48 h. The primary antibodies used were: 1:500
sheep anti-tyrosine hydroxylase (Chemicon); 1:1,000 rabbit anti-cone
arrestin antibody Luminaire junior; 1:1,000 rabbit anti-M-opsin;
1:1,000 rabbit anti-S-opsin (cone antibodies were kind gifts from Dr.
Craft, University of Southern California); 1:1,000 mouse anti-
calbindin (Chemicon); 1:1,500 rabbit anti-CaBP5 (a gift from Dr.
Haeseleer, University of Washington); 1:3,000 mouse anti-calretinin
(Chemicon); and 1:2,000 rabbit anti-melanopsin (a gift from Dr.
Provencio, University of Virginia). After rinsing, a secondary
incubation was performed for 2 h with either 1:500 Alexa Fluor 488
donkey anti-sheep IgG, 1:500 Alexa Fluor 488 donkey anti-rabbit IgG,
or 1:500 Alexa Fluor 594 donkey anti-mouse IgG (all purchased from
Molecular Probes). Samples were mounted and cover slipped using
Vectashield (Vector Laboratories) and then visualized using Zeiss
LSM5 PASCAL confocal microscopy (Carl Zeiss).
HPLC. The total content of dopamine from retinal explants was
determined by HPLC in the Vanderbilt Neurochemistry Core Lab.
The HPLC system consisted of a 515 HPLC pump (Waters), a 717 plus
autosampler (Waters), a Decade II (oxidation: 0.5) electrochemical
detector (Antec Leyden), and a Nucleosil (5 lm, 100 A ˚ ) C18 HPLC
column (150 3 4.6 mm; Phenomenex). The retinal samples were ﬁrst
homogenized in 200 ll of 0.1 M TCA, which contains 10 mM sodium
acetate, 0.1 mM EDTA, and 10.5% methanol (pH 3.8), and then
centrifuged at 10,000 g for 20 min, ﬁltered on a 0.2-lm pore size ﬁlter.
A total of 20 ll of each sample was directly injected into the HPLC
system. The mobile phase was composed of 89.5% 0.1 M TCA, 10 mM
sodium acetate, 0.1 mM EDTA, and 10.5% methanol (pH 3.8). The
mobile phase ﬂow rate was set to 0.6 ml/min and the electrochemical
detector to 33 8C. HPLC control and data acquisition were managed
by Millennium 32 software (Waters).
Quantitative real-time PCR. To determine the transcript levels of
core clock genes in GABA- and vehicle-treated retinal explants,
retinal explants were homogenized 8 h after treatment started at the
beginning of the third circadian cycle, and total RNA extraction and
real-time RT-PCR were performed as previously described [43]. The
housekeeping gene glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) was used as a reference gene for normalization. For data
analysis, the threshold cycle (Ct) was converted to absolute amount of
transcript (E
 Ct) and presented as E
Ct GAPDH -Ct gene of interest. The
mean value of E
Ct GAPDH -Ct gene of interest for vehicle was normalized to
1.0. A Student’s t-test was applied to compare clock gene expression
levels between treatment and vehicle.
Data analysis. Student’s t-test was routinely performed to compare
the difference in the damping rate, period, phase, and A4/A2 ratio
between drug- and vehicle-treated samples. For GABAA and GABAC
antagonists treatment, two-way repeated-measures ANOVAs were
run for both drug and vehicle control in which the variances were
homogeneous, as indicated by a signiﬁcant Levene test. For post hoc
analysis of signiﬁcant interactions, independent t-tests with a
Bonferroni-corrected alpha (the alpha was Bonferroni corrected by
the number of comparisons) were used to compare the effects of drug
for each cycle.
Supporting Information
Figure S1. Mouse Retinas Show Low Amplitude PER2::LUC
Oscillations When Directly Cultured in Medium 199 (A) or DMEM (B)
Found at doi:10.1371/journal.pbio.0060249.sg001 (1.61 MB TIF).
Figure S2. Temporal Expression Proﬁles of Six Core Clock Genes in
the Mouse Retina under 12-h Light:12-h Dark (Filled Circles) and
Constant Darkness (Open Circles) Conditions
Quantitative real-time RT-PCR and data analysis were performed as
in [43]. Data are presented as means 6 SEM from ﬁve B6C3F1 mice
and expressed as a percentage of the maximum mean expression.
Points at ZT/CT [2] are duplicates of ZT/CT 2 replotted to show 24-h
trends. Under 12-h light:12-h dark condition, one-way ANOVA
revealed p , 0.001 for Per2, Cry2, and Bmal1, and p , 0.05 for Per1,
Cry1, and Clock. The peak-to-trough amplitudes for Per1, Per2, Cry1,
Cry2, Clock, and Bmal1 expression were 1.27-, 1.50-, 1.29-, 1.49-, 1.33-,
and 1.30-fold, respectively. Under constant darkness condition, one-
way ANOVA revealed p , 0.001 for Per1, Per2, and Cry1, p , 0.05 for
Bmal1,a n dp . 0.05 for Cry2 and Clock. The peak-to-trough
amplitudes for Per1, Per2, Cry1, and Bmal1 expression under constant
darkness were 1.40-, 2.12-, 1.47-, and 1.20-fold, respectively.
Found at doi:10.1371/journal.pbio.0060249.sg002 (4.44 MB TIF).
Figure S3. All the Major Retinal Cell Types Are Morphologically
Intact in Cultured Mouse Retinal Explants
Flat-mount view showing immunoreactivity for cone photoreceptors
([A–C]; anti-cone arrestin, M-opsin, and S-opsin; green), horizontal
cells ([D]; anti-calbindin; focused on the horizontal cell layer; red),
bipolar cells ([E]; anti-CaBP5; green), amacrine cells ([F]; anti-
calretinin; red), and melanopsin-containing ganglion cells ([G]; anti-
melanopsin; green). Retinal explants were cultured for 5 d in vitro
(DIV; 1 d in 5% CO2 incubator and 4 d in the LumiCycle) before
immunocytochemistry. Scale bar represents 20 lm.
Found at doi:10.1371/journal.pbio.0060249.sg003 (3.55 MB TIF).
Figure S4. GABA Does Not Suppress SCN Ensemble PER2::LUC
Rhythms
Found at doi:10.1371/journal.pbio.0060249.sg004 (4.21 MB TIF).
Figure S5. Actions of GABA Receptor Agonists on Retinal
PER2::LUC Rhythms
Shown are representative PER2::LUC bioluminescence traces of
mouse retinal explants treated with: (A) the GABAA receptor agonist
muscimol (200 lM); (B) the GABAB receptor agonist baclofen (200
lM); (C) the GABAC receptor agonist CACA (50 lM); (D) muscimol
(200 lM) and baclofen (200 lM); (E) baclofen (200 lM) and CACA (50
lM); and (F) muscimol (200 lM) along with baclofen (200 lM) and
CACA (50 lM). Bars indicate the duration of treatment.
Found at doi:10.1371/journal.pbio.0060249.sg005 (4.19 MB TIF).
Figure S6. Actions of GABA Receptor Antagonists on the Inhibitory
Effect of GABA on Retinal PER2::LUC Rhythms
Shown are representative PER2::LUC bioluminescence traces of
mouse retinal explants treated with 1 mM GABA along with: (A)
the GABAA receptor antagonist SR-95531 (40 lM); (B) the GABAB
receptor antagonist CGP-35348 (100 lM); (C) the GABAC antagonist
TPMPA (100 lM); (D) SR-95531 (40 lM) and CGP-35348 (100 lM); (E)
CGP-35348 (100 lM) and TPMPA (100 lM); and (F) SR-95531 (40 lM),
CGP-35348 (100 lM), and TPMPA (100 lM). Bars indicate the
duration of treatment.
Found at doi:10.1371/journal.pbio.0060249.sg006 (4.17 MB TIF).
Figure S7. Actions of GABA Receptor Antagonists on Retinal
PER2::LUC Rhythms
Shown are representative PER2::LUC bioluminescence traces of
mouse retinal explants treated with: (A) the GABAA receptor
antagonist SR-95531 (40 lM); (B) the GABAB receptor antagonist
CGP-35348 (100 lM); (C) the GABAC antagonist TPMPA (100 lM); (D)
SR-95531 (40 lM) and CGP-35348 (100 lM); and (E) CGP-35348 (100
lM) and TPMPA (100 lM). Bars indicate the duration of treatment.
Found at doi:10.1371/journal.pbio.0060249.sg007 (4.24 MB TIF).
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